Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 3:02 pm Purchase |
2021-12-31 | 13G | Sana Biotechnology, Inc. SANA |
Flagship Ventures Fund V, L.P. | 34,239,018 18.100% |
34,239,018![]() (New Position) |
Filing History |
2022-02-10 5:12 pm Purchase |
2021-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,078,591 23.300% |
44,078,591![]() (New Position) |
Filing History |
2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 8,627,851 4.569% |
-822,410![]() (-8.70%) |
Filing History |
2022-01-26 07:03 am Purchase |
2021-12-31 | 13G | Sana Biotechnology, Inc. SANA |
BAILLIE GIFFORD & CO | 11,262,030 5.960% |
11,262,030![]() (New Position) |
Filing History |
2021-02-10 09:23 am Purchase |
2021-02-09 | 13G | Sana Biotechnology, Inc. SANA |
FMR CORP | 9,450,261 5.390% |
9,450,261![]() (New Position) |
Filing History |